semaglutide and fatty liver 🧬 New Option for Disease The TGA has provisionally approved Wegovy (semaglutide) for adults with MASH moderate to advanced liver fibrosis. ✓ Early intervention is key ✓ Many patients Semaglutide might be a key

The most frequently reported symptoms involve the digestive system and may include: Nausea Vomiting Diarrhea Constipation Abdominal pain or discomfort Bloating or increased fullness Heartburn, indigestion, or burping Reduced appetite Some patients experience very mild symptoms, while others need additional support or a slower treatment progression

Do not shake, swirl, or invert the vial after adding water

Oxidative Stress Explained Oxidative stress is when reactive oxygen species (ROS) and other free radicals overwhelm the antioxidant defenses that neutralize them

Nevertheless, other randomized clinical trials failed to demonstrate any beneficial effect of selenium supplementation in GD (81, 82) or in HT [79, 80]